Skip to content
drillr.ai

RCEL

AVITA Medical, Inc.

NASDAQ · USHealthcareMedical - Devices
$5.14+0.78%

Price as of Jul 20, 2026

RCEL news

AVITA Medical, Inc. news

A server-rendered, paginated timeline of the latest available company news.

  1. AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting

    * First U.K. case series demonstrates successful use of RECELL GO(®) in 17 burn and reconstructive surgery patients * Findings presented at the British Burn Association Annual Meeting support the role of RECELL GO in standardizing preparation of RECELL(®) Spray-On Skin™ Cells and improving operating room workflow * RECELL GO is CE-marked in Europe and the U.K. and recently received regulatory authorization in Australia and New Zealand VALENCIA, Calif., June 18, 2026 (GLOBE NEWSWIRE) -- AVITA

    Globe Newswire ·

  2. INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AVITA Medical Inc. - RCEL

    NEW YORK CITY, NY / ACCESS Newswire (https://www.accessnewswire.com/) / May 13, 2026 / Pomerantz LLP is investigating claims on behalf of investors of AVITA Medical Inc. ("AVITA Medical" or the "Company") (NASDAQ:RCEL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether AVITA Medical and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click

    ACCESSWIRE ·

  3. AVITA Medical Names Cary Vance as Chief Executive Officer

    * Board appoints Cary Vance as President and Chief Executive Officer * Follows successful interim tenure and thorough search process by the Board * Jan Stern Reed elected as Chair of the AVITA Medical Board VALENCIA, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- AVITA Medical(®), Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company, today announced that its Board of Directors has appointed Cary Vance as President and Chief Executive Officer, effective immediately. The

    Globe Newswire ·

  4. AVITA Medical to Announce First Quarter 2026 Financial Results

    VALENCIA, Calif., April 23, 2026 (GLOBE NEWSWIRE) -- AVITA Medical(®), Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company, today announced that it will report its first quarter 2026 financial results after the close of the U.S. financial markets on Thursday, May 14, 2026. AVITA Medical will host a conference call and webcast that day at 1:30 p.m. Pacific Time (Friday, May 15, 2026, at 6:30 a.m. Australian Eastern Standard Time) to discuss its financial results and rece

    Globe Newswire ·

  5. AVITA Medical Founder Fiona Wood Honored with Lifetime Achievement Award by American Burn Association

    * Recognition highlights pioneering contributions to modern burn care including development of RECELL(®) Spray-On Skin™ VALENCIA, Calif., April 15, 2026 (GLOBE NEWSWIRE) -- AVITA Medical(®), Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company, today announced that its founder, Professor Fiona Wood, has been awarded the Lifetime Achievement Award by the American Burn Association (ABA). The award, the ABA’s highest honor, recognizes individuals whose enduring contribution

    Globe Newswire ·

  6. AVITA Medical Announces Positive Interim Results from Cohealyx® Study Demonstrating Accelerated Time to Skin Grafting

    * Mean time to graft reduced to 13.6 days vs. 33.2 days real-world benchmark (~20 day reduction) * Median time to graft of 11 days, with grafting as early as 5 days * Study ongoing with full dataset expected in 2026 * Management to host Key Opinion Leader webinar at 4:30 p.m. ET on April 16 during the American Burn Association Annual Meeting VALENCIA, Calif., April 14, 2026 (GLOBE NEWSWIRE) -- AVITA Medical(®), Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company, tod

    Globe Newswire ·

  7. AVITA Medical Showcases Acute Burn and Wound Care Portfolio at ABA 2026, Featuring New Cohealyx Data

    * Cohealyx® multi-center study interim analysis and new case data to be presented * RECELL® and PermeaDerm® data reinforce a comprehensive approach to wound healing * Evidence demonstrates potential to improve outcomes while reducing hospital length of stay and optimizing resource utilization VALENCIA, Calif., April 07, 2026 (GLOBE NEWSWIRE) -- AVITA Medical®, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company, today announced its presence at the 2026 American Burn Ass

    Globe Newswire ·